Vice President, Global Head of Communications

Scholar Rock

Cambridge, MA Onsite Global Operations Full-Time

About this role

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.

Summary of Position:

We are seeking a strategic, and highly collaborative Vice President & Global Head of Communications to lead our global communications function. The leader will shape and drive all enterprise, executive and business communications strategies and efforts to strengthen our reputation, engage stakeholders, and advance our business and brand across internal and external audiences.

The ideal candidate will bring a bold communications vision, deep experience and perspective to a diverse range of topics and issues, a track record of influencing and enabling business strategy, and the ability to be agile and lead through complexity, change, and opportunity. This position reports to the Chief Operating Officer and will partner closely with the CEO, the entire executive team and key business leaders to ensure communications are aligned, forward-looking, and aligned with our mission to bring medicine to the communities we serve and become the next great commercial biotech company globally.